ABVX (Abivax Corp) Market Value to Book Value Ratio

Official company branding of ABIVAX (ABVX)

ABIVAX is developing breakthrough treatments to combat chronic intestinal inflammation, offering solutions even when standard methods prove ineffective. The company is implementing automated molecule screening to optimize compound analysis costs. This chart reflects a price trend at 16.69, while the biotech firm expands its B2B clinic segment, aiming to ensure long-term recovery for patients with Crohn's disease and colitis.

ABVX Abivax S.A.: Market Value to Book Value in the range 02/21/2024 - 10/28/2026

Financial and market metric breakdowns for abivax.com (ABVX)

- price and consensus price forecast:
Stock Quotes Abivax Corp|ABVX - Broker Consensus Forecast
- market capitalization data:
Market Value Abivax Pharma|ABVX - Full Business Value
- book capitalization data:
Book Value per Share Abivax|ABVX - Accounting Value of Company|Market Capitalization to Book Value Ratio abivax.com|ABVX - Company Total Assets
- debt and liquidity data:
Debt to Equity ABIVAX|ABVX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Abivax|ABVX - Company Total Debt|Debts to Book Capitalization Abivax Pharma
Initial company analysis:Abivax S.A. - ABVX
Original product of Abivax

This ratio measures the gap between the market price of shares and the value of net assets, determining the size of the premium the market is willing to pay for the business's future potential. In the case of ABIVAX (ABVX), the ratio of the company's market value to its book assets reflects investor expectations regarding the success of obefazimod, turning this chart into an indicator of market confidence in a future blockbuster.

Main competitors

Market Cap to Net Assets Ratio argenx SE|BNTX (biontech.de) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio ADMA Biologics, Inc. ADMA|Market Capitalization to Net Assets Protagonist Therapeutics, Inc.|Immunovant Corp (IMVT) - Market Capitalization to Book Value Ratio|Market Value to Book Value Kiniksa Corp (KNSA)|Market Capitalization to Book Value Ratio GRFS (Grifols, S.A.)|adaptivebiotech.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Celldex Therapeutics, Inc. (CLDX)|AUPH: Market Value to Book Value|BCRX (BioCryst Pharmaceuticals Inc) - Market Value to Book Value Ratio|Vera Corp (VERA) - Market Cap to Net Assets Ratio|DNTH (Dianthus Therapeutics) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio pharvaris.com (PHVS)|AbCellera Bio (ABCL) - Market Cap to Net Assets Ratio|Market Value to Book Value Tourmaline Bio Inc (TRML)|Market Capitalization to Book Value Ratio PGEN|Pharming Corp - Market Capitalization to Book Value|NKTR: Market Value to Book Value Ratio|UPB: Market Cap to Net Assets Ratio|ZBIO (Zenas Biopharma) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Immunome Inc|GOSS (Gossamer Corp) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio KALV|Market Value to Book Value Ratio Septerna Inc SEPN|Capitalization to Book Value Ratio pieris.com (PVLA)|SVRA: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Rigel Pharma RIGL|AnaptysBio Corp - Market Capitalization to Book Value Ratio|ATXS - Market Capitalization to Book Value Ratio|enGene Holdings Inc. (ENGN) - Market Capitalization to Book Value Ratio|rapt.com (RAPT) - Market Value to Book Value Ratio|JBIO: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Aclaris Therapeutics Inc. (ACRS)|Market Cap to Net Assets Ratio Kyverna (KYTX)|Market Value to Book Value Ratio Tiziana Life Sciences, Ltd. (TLSA)|Market Capitalization to Book Value Ratio CABA (Cabaletta Bio, Inc.)|VTYX - Market Capitalization to Book Value Ratio|Theratechnologies (THTX) - Market Cap to Net Assets Ratio|AVTX - Capitalization to Book Value Ratio|ELDN: Market Capitalization to Book Value Ratio|Agenus, Inc (AGEN) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Climb Bio Inc|Market Value to Book Value Ratio zurabio.com (ZURA)|Market Cap to Net Assets Ratio aTyr Pharma (ATYR)|Market Value to Book Value Ratio adagene.com ADAG|IMA - Market Cap to Net Assets Ratio|Shattuck Labs Inc - Capitalization to Book Value Ratio|Market Value to Book Value Ratio Equillium Bio|CNTB - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio immunic-therapeutics.com IMUX|Atara Bio (ATRA) - Market Value to Book Value|IFRX (InflaRx NV) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio XFOR|Adicet Bio (ACET) - Market Value to Book Value Ratio|Market Value to Book Value CELU (celularity.com)|INmune Bio - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc - Market Capitalization to Book Value Ratio|SAB Biotherapeutics Inc (SABS) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Akari Therapeutics AKTX|Enlivex Therapeutics Ltd. (ENLV) - Market Value to Book Value|QTTB: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value GOVX|Market Value to Book Value Ratio EDSA (Edesa)|Market Cap to Net Assets Ratio IBIO (iBio Corporation)|Carisma Therapeutics Inc. - Market Value to Book Value Ratio|XTLB - Market Cap to Net Assets Ratio|Bolt Bio - Market Cap to Net Assets Ratio|HCWB: Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio aptevotherapeutics.com|aimimmuno.com (AIM) - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ADTX (Aditxt Inc.)|Market-to-Book Ratio gribio.com|Market Capitalization to Book Value Ratio XRTX|Market Capitalization to Book Value Ratio Vyome Holdings Inc. (HIND)|Market Capitalization to Book Value Ratio Revelation Bio REVB|Market Value to Book Value Ratio Indaptus Corp INDP|Market Capitalization to Book Value Ratio SCNI (Scinai Immunotherapeutics)|CalciMedica, Inc. (CALI) - Market Capitalization to Book Value|affimed.com (AFMD) - Market Cap to Net Assets Ratio|Allakos (ALLK) - Market Value to Book Value Ratio|HOOK (HOOKIPA Pharma, Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio IGM Bio (IGMS)|Market Cap to Net Assets Ratio iTeos Therapeutics ITOS|Capitalization to Book Value Ratio oceanbiomedical.com (OCEA)|Market Capitalization to Book Value Ratio TCBP (TC BioPharm)|Market Capitalization to Book Value Ratio Third Harmonic Bio Inc. THRD